In January of this year, Google X Lab praised the development of contact lenses with a miniature chip, measuring the level of glucose in tears. Today, Mountain View has announced that it has partnered with one of the largest pharmaceutical companies in the world, which aims to bring the product to market.
Swiss company Novartis apparently sees in this type of sensors big money. The company, which last year recorded the highest sales of all firms in the industry , intends to invest in the development of the technology developed byGoogle X Lab through dealing with ophthalmology subsidiary Alcon. Novartis has already acquired a license to technology developed by Google and intends to introduce it to the market.
"We are pleased that we can work together with Google to connect their advanced technology with our extensive knowledge of the biology and together satisfy unmet medical needs," said CEO of NovartisJoseph Jimenez. "It is extremely important for us to start from ophthalmology, to go beyond the existing boundaries of the treatment of diseases.""Our dream is to make use of the latest technology miniaturization of electronics, improve the quality of life of millions of people," added Sergey Brin. "We are pleased that we will be able to realize this dream together with Novartis."
In addition to business plans to market lenses for diabetics, the agreement also provides for cooperation in research on more advanced contact lenses fitted with microchips. Novartis suggests that such lenses may, for example, automatically in accommodating alleviate eye problems that arise in the case of presbyopia .
Although it sounds very interesting, keep in mind that it will be some time before the pharmacy you can buy contact lenses that measure glucose levels and wirelessly transmit data about mobile device. When Google claimed the prototype, the company claimed that the development of the final product should take about five years.
SOURCE-GIZNET
0 comments:
Post a Comment